[{"address1": "CAP Business Center", "address2": "Rue d\u2019Abhooz 31 Zone Industrielle des Hauts-Sarts", "city": "Herstal", "zip": "4040", "country": "Belgium", "phone": "32 4 257 70 21", "website": "https://mdxhealth.com", "industry": "Diagnostics & Research", "industryKey": "diagnostics-research", "industryDisp": "Diagnostics & Research", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "MDxHealth SA, a commercial-stage precision diagnostics company, provides urologic solutions in the United States, Europe, and internationally. Its novel prostate cancer genomic testing solutions are SelectMDx, a non-invasive urine test; and ConfirmMDx, an epigenetic test, which provide physicians with a clinical pathway to identify clinically prostate cancer while minimizing the use of invasive procedures that are prone to complications. The company was formerly known as OncoMethylome Sciences SA and changed its name to MDxHealth SA in October 2010. MDxHealth SA was incorporated in 2003 and is headquartered in Herstal, Belgium.", "companyOfficers": [{"maxAge": 1, "name": "Mr. Michael K. McGarrity", "age": 60, "title": "CEO & Executive Director", "yearBorn": 1963, "fiscalYear": 2022, "totalPay": 577764, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Ron  Kalfus", "age": 49, "title": "Chief Financial Officer", "yearBorn": 1974, "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Joseph  Sollee", "age": 58, "title": "Executive VP of Corporate Development & General Counsel", "yearBorn": 1965, "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. John A. Bellano", "age": 54, "title": "Chief Commercial Officer", "yearBorn": 1969, "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Miriam  Reyes", "age": 50, "title": "Executive Vice President of Operations", "yearBorn": 1973, "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Jason  Poole Ph.D.", "title": "Chief Scientific Officer", "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 7, "boardRisk": 4, "compensationRisk": 10, "shareHolderRightsRisk": 1, "overallRisk": 7, "governanceEpochDate": 1709251200, "compensationAsOfEpochDate": 1672444800, "maxAge": 86400, "priceHint": 4, "previousClose": 2.58, "open": 2.66, "dayLow": 2.62, "dayHigh": 3.2, "regularMarketPreviousClose": 2.58, "regularMarketOpen": 2.66, "regularMarketDayLow": 2.62, "regularMarketDayHigh": 3.2, "beta": -379681.88, "forwardPE": -4.507693, "volume": 402673, "regularMarketVolume": 402673, "averageVolume": 85528, "averageVolume10days": 129192, "averageDailyVolume10Day": 129192, "bid": 2.23, "ask": 3.41, "bidSize": 200, "askSize": 200, "marketCap": 79954136, "fiftyTwoWeekLow": 0.001, "fiftyTwoWeekHigh": 4.64, "priceToSalesTrailing12Months": 1.1390613, "fiftyDayAverage": 3.31402, "twoHundredDayAverage": 3.19568, "currency": "USD", "enterpriseValue": 86503464, "profitMargins": -0.61402, "floatShares": 16998346, "sharesOutstanding": 27288100, "sharesShort": 23350, "sharesShortPriorMonth": 6908, "sharesShortPreviousMonthDate": 1707955200, "dateShortInterest": 1710460800, "sharesPercentSharesOut": 0.00090000004, "heldPercentInsiders": 0.02626, "heldPercentInstitutions": 0.40297002, "shortRatio": 0.32, "shortPercentOfFloat": 0.0013, "impliedSharesOutstanding": 28164800, "bookValue": 0.262, "priceToBook": 11.183207, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1703980800, "netIncomeToCommon": -43100000, "trailingEps": -2.1, "forwardEps": -0.65, "enterpriseToRevenue": 1.232, "enterpriseToEbitda": -4.226, "52WeekChange": 2929.0, "SandP52WeekChange": 0.2726959, "exchange": "NCM", "quoteType": "EQUITY", "symbol": "MDXH", "underlyingSymbol": "MDXH", "shortName": "MDxHealth SA", "longName": "MDxHealth SA", "firstTradeDateEpochUtc": 1636032600, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EDT", "uuid": "e97b45b6-9430-3bb3-a498-f3ee26ac6d63", "messageBoardId": "finmb_4803148", "gmtOffSetMilliseconds": -14400000, "currentPrice": 2.93, "targetHighPrice": 15.0, "targetLowPrice": 6.0, "targetMeanPrice": 8.4, "targetMedianPrice": 7.0, "recommendationMean": 1.3, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 5, "totalCash": 22380000, "totalCashPerShare": 0.814, "ebitda": -20468000, "totalDebt": 41265000, "quickRatio": 1.714, "currentRatio": 1.955, "totalRevenue": 70193000, "debtToEquity": 572.489, "revenuePerShare": 2.703, "returnOnAssets": -0.13758999, "returnOnEquity": -5.2169704, "freeCashflow": -20070376, "operatingCashflow": -21497000, "revenueGrowth": 0.505, "grossMargins": 0.62583, "ebitdaMargins": -0.2916, "operatingMargins": -0.32509, "financialCurrency": "USD", "trailingPegRatio": null, "__fetch_time": "2024-04-03"}]